vabbè, si ha sempre il 50 di possibilità o va su o va giù... fosse uscita una news buona non saremmo qui a criticarla
mah mi son messo un po a sfruculiare questo l'avete letto:
From November 22, 2017 through January 25, 2018, the holder of the Series A Convertible Preferred Stock, par value $0.01 per share (the “Preferred
Stock”), of Microbot Medical Inc. (the “Registrant”), converted an aggregate of 2,436 shares of the Preferred Stock for an aggregate of 2,436,000 shares of the
Registrant’s common stock. Pursuant to the terms of conversion of the Preferred Stock, each such share is convertible, upon request and for no additional
consideration, into 1,000 shares of the common stock of the Registrant. The issuances of the 2,436,000 shares of common stock were exempt from registration
under Section 4(a)(2) under the Securities Act of 1933, as amended and the rules promulgated thereunder (the “Securities Act”) as transactions not involving
a public offering to a single existing stockholder who is an accredited investor, and/or 3(a)(9) under the Securities Act as the Preferred Stock was exchanged
for common stock by an existing security holder and no commission or other remuneration was paid.
On January 31, 2018, the Registrant issued a press release announcing that it will host regularly scheduled Townhall Meetings to allow shareholders
and interested investors to get updates and participate in a Q&A session with senior executives of the Company. The initial Townhall Meeting is scheduled
for Thursday, February 1, 2018 at 4:30pm ET.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information
in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the
materiality of any information herein (including Exhibit 99.1).
